Avalo Therapeutics (AVTX) Gross Margin (QoQ) (2017 - 2023)

Avalo Therapeutics (AVTX) Gross Margin (QoQ) (2017 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Avalo Therapeutics 1.04 Mn 1.04 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 14,337.00
Sep 30, 2023 545.00
Jun 30, 2023 589.00
Mar 31, 2023 -4,680.00
Dec 31, 2022 -6,566.00
Sep 30, 2022 14,816.00
Jun 30, 2022 -9,031.00
Mar 31, 2022 13,223.00
Dec 31, 2021 -12,635.00
Sep 30, 2021 -6,479.00
Jun 30, 2021 1,381.00
Mar 31, 2021 -1,100.00
Dec 31, 2020 165.00
Sep 30, 2020 -110.00
Jun 30, 2020 -343.00
Mar 31, 2020 2,380.00
Dec 31, 2019 -2,018.00
Sep 30, 2019 10,089.00
Jun 30, 2019 -7,770.00
Mar 31, 2019 464.00